Show simple item record

dc.contributor.authorSoldatow, Valerie Y.
dc.contributor.authorLeCluyse, Edward L.
dc.contributor.authorGriffith, Linda G.
dc.contributor.authorRusyn, Ivan
dc.date.accessioned2014-08-20T16:26:24Z
dc.date.available2014-08-20T16:26:24Z
dc.date.issued2013
dc.date.submitted2012-07
dc.identifier.issn2045-452X
dc.identifier.issn2045-4538
dc.identifier.urihttp://hdl.handle.net/1721.1/88931
dc.description.abstractOver the years, various liver-derived in vitro model systems have been developed to enable investigation of the potential adverse effects of chemicals and drugs. Liver tissue slices, isolated microsomes, perfused liver, immortalized cell lines, and primary hepatocytes have been used extensively. Immortalized cell lines and primary isolated liver cells are currently the most widely used in vitro models for liver toxicity testing. Limited throughput, loss of viability, and decreases in liver-specific functionality and gene expression are common shortcomings of these models. Recent developments in the field of in vitro hepatotoxicity include three-dimensional tissue constructs and bioartificial livers, co-cultures of various cell types with hepatocytes, and differentiation of stem cells into hepatic lineage-like cells. In an attempt to provide a more physiological environment for cultured liver cells, some of the novel cell culture systems incorporate fluid flow, micro-circulation, and other forms of organotypic microenvironments. Co-cultures aim to preserve liver-specific morphology and functionality beyond those provided by cultures of pure parenchymal cells. Stem cells, both embryonic- and adult tissue-derived, may provide a limitless supply of hepatocytes from multiple individuals to improve reproducibility and enable testing of the individual-specific toxicity. This review describes various traditional and novel in vitro liver models and provides a perspective on the challenges and opportunities afforded by each individual test system.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (P42 ES005948)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (R01 ES01524)en_US
dc.language.isoen_US
dc.publisherRoyal Society of Chemistryen_US
dc.relation.isversionofhttp://dx.doi.org/10.1039/c2tx20051aen_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourcePMCen_US
dc.titleIn vitro models for liver toxicity testingen_US
dc.typeArticleen_US
dc.identifier.citationSoldatow, Valerie Y., Edward L. LeCluyse, Linda G. Griffith, and Ivan Rusyn. “In Vitro Models for Liver Toxicity Testing.” Toxicol. Res. 2, no. 1 (2013): 23.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Mechanical Engineeringen_US
dc.contributor.mitauthorGriffith, Linda G.en_US
dc.relation.journalToxicology Researchen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsSoldatow, Valerie Y.; LeCluyse, Edward L.; Griffith, Linda G.; Rusyn, Ivanen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-1801-5548
mit.licenseOPEN_ACCESS_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record